Cannabis Business News for Executives and Investors: How to Stay Ahead in 2026
Cannabis executives and investors don’t need more headlines. They need to know which developments change cash flow, valuations and strategy, and they need that quickly. In 2026 that list is long: partial federal rescheduling, a stalled DEA proceeding, uplistings to major exchanges, falling retail prices and a new wave of M&A.
This guide covers what to track, why it matters, and where IgniteIt fits in for business readers.
What cannabis executives and investors should track in 2026
1. Rescheduling and federal policy
Medical cannabis moved to Schedule III in April 2026, while adult-use remains Schedule I pending a DEA proceeding that was paused in September. Every step affects taxes, listings and valuations. Our rescheduling timeline is kept up to date.
2. Taxes and Section 280E
For many operators, 280E is the single biggest line item. Schedule III removes it going forward for qualifying medical operations, but past 280E taxes are unlikely to come back.
3. Capital markets: listings, debt and M&A
Trulieve and Glass House have moved to the NYSE. Lenders are separating bankable operators from the rest. And contested deals like Curaleaf’s bid for Aurora show where consolidation is heading.
4. State market economics
Prices are still falling in most markets, and companies are still expanding into them. State-level analysis, like IgniteIt’s coverage of Colorado’s mature market and Pennsylvania’s adult-use debate, helps explain which bets make sense.
5. Leadership strategy
The fastest way to understand a company’s direction is to hear it from its leaders. IgniteIt’s executive interviews cover CEOs, CFOs and investors across multistate operators, REITs and international companies.
Where IgniteIt fits
IgniteIt is a cannabis business news, intelligence and events company built for this audience. It combines three things executives usually have to piece together from different places:
- Daily business news: earnings, financings, M&A, rescheduling and state markets, written for operators and investors. Read the latest.
- Weekly intelligence: IgniteIt Intelligence explains what filings, deal terms and pricing data mean for strategy and valuation. Learn more about the weekly briefing.
- Events: the Cannabis Capital Conference, the Capital & Policy Summit in Washington, and state Market Spotlights, where operators and investors meet in person.
IgniteIt’s leadership previously ran Benzinga Cannabis and the Cannabis Capital Conference. The company launched independently in 2025.
Building your information stack
Most executives combine:
- Business news and analysis. IgniteIt, plus a policy tracker like Marijuana Moment. See our guide to the best cannabis news sites.
- Market data. Retail sales, pricing and deal data. See our guide to cannabis market intelligence providers.
- In-person access. One or two capital-focused events a year.
Frequently asked questions
Where do cannabis investors get their news?
Investors typically combine business-focused outlets such as IgniteIt with a policy tracker like Marijuana Moment, plus deal and pricing data from specialist providers.
What cannabis news matters most to executives right now?
Rescheduling and its effect on Section 280E, access to capital and exchange listings, M&A, and state-level pricing.
Is IgniteIt free?
IgniteIt’s daily news and the Intelligence archive are free to read online, and readers can sign up for the newsletter.
